Nomura Healthcare FundDLHAX
Type
Mutual fund
Peer group
Global equity
Net assets
$665.0M
Expense ratio
1.21%
1-year return
+17.4%
3 years, a year
+11.5%
5 years, a year
+7.1%
Holdings
106
What it aims to do.
Macquarie Healthcare Fund seeks maximum long-term capital growth through capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| JOBY Ucb Sa | 5.90% |
| REGN Regeneron Pharmaceuticals, Inc. | 5.46% |
| PFE Pfizer Inc. | 4.83% |
| GILD Gilead Sciences Inc. | 4.40% |
| ABBV AbbVie Inc. | 4.09% |
| MRK Merck & Co., Inc | 3.89% |
| JOBY AstraZeneca PLC | 3.86% |
| JOBY Chugai Pharmaceutical Co Ltd. | 3.73% |
| LLY Eli Lilly & Co. | 3.60% |
| JOBY Roche Holding AG | 3.30% |
More on DLHAX.
- DLHAX overview
- DLHAX holdings
- DLHAX risk
- DLHAX costs
- DLHAX money in and out
- DLHAX share classes
- Compare DLHAX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.